GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Stryker Corporation (SYK) [hlAlert]

Rating:
Outperform
SYK
up 35.24 %

Stryker Corporation (SYK) rated Outperform by Bernstein

Posted on: Monday,  Nov 25, 2013  8:25 AM ET by Bernstein

Bernstein rated Outperform Stryker Corporation (NYSE: SYK) on 11/25/2013, when the stock price was $74.74. Since
then, Stryker Corporation has gained 35.24% as of 01/08/2016's recent price of $101.08.
If you would have followed this Bernstein's recommendation on SYK, you would have gained 35.24% of your investment in 774 days.

Stryker Corporation (Stryker) is a medical technology company with a range of products in orthopaedics and a presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose and throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. The Company operates in two business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, craniomaxillofacial and spinal implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment.

A central advantage for Bernstein clients is the ability to harness our highly regarded expertise in investment research and management. Originally known as a value investor, Bernstein has long been known for seeking out stocks with temporarily depressed prices due to unwarranted short-term pessimism about a company’s ability to recover from its current problems. This philosophy is embodied in our flagship Strategic Value portfolio. But since value and growth stocks have alternated leadership—with no clear signal of when one style will give way to the other—we’ve developed a Strategic Growth portfolio that seeks out leading companies whose stock prices don’t fully reflect their companies’ potential for superior earnings growth.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/25/2013 8:25 AM Buy
None
74.74
as of 12/13/2013
1 Week down  -3.97 %
1 Month down  -4.25 %
3 Months   
1 YTD down  -4.25 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy